EN
CN EN
SUYA-IM
Human Immunoglobulin for Intramuscular Injection (10%)
Name
Human Immunoglobulin for Intramuscular Injection (10%)
Use within
36 months
Specifications
150mg/vial (10%, 1.5ml)
300mg/vial (10%, 3ml)
Approval number
NMPA Approval No. S10980027
NMPA Approval No. S10980028
Indications
Mainly used for the prevention of measles and infectious hepatitis. When used in combination with antibiotics, it can enhance the efficacy against certain severe bacterial and viral infections.